A 2-Week Double-Blind, Placebo-Controlled, Parallel Group Study Comparing the Anti-Inflammatory Effects of Low, Medium, and High Dose Mometasone Furoate/Formoterol Fumarate MDI Formulation and Medium Dose Mometasone Furoate DPI and MDI Formulations in Adults and Adolescents With Persistent Allergic Asthma.
Phase of Trial: Phase II
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Mometasone/formoterol (Primary) ; Mometasone
- Indications Allergic asthma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2009 Planned end date changed from 1 Apr 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History